Openbookopenbook
Equity
TurnKey Capital Inc(TKCI)
USD --+0.00%
Reward47Moderate
Risk53Moderate
📊50%Data
TKCI
+0.0 · +0.00%
USD · PINK
TurnKey Capital Inc | Technology
Balanced
Market Cap:59.77M
ℹ️
Reward Rating
47
Moderate
Bottom 25% (model universe)
50% data coverage
ℹ️
Risk Rating
53
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on TKCI to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is TurnKey Capital Inc?

develops marijuana based intravenous therapy (IV) infusion blends for healthcare practitioners.

TKCI · Verdict

Moderate reward · elevated risk

TKCI's standout is balance sheet; volatility and cash flow weigh on the picture.

Based on 75% data coverage

TKCI · Verdict

What’s working & what to watch

Strengths 1

  • Balance sheet93/100

    Current ratio 516.33

Watchouts 3

  • Volatility5/100

    Weak vs peers

  • Cash flow37/100

    -14% free-cash-flow margin

  • Profitability40/100

    99% net margin · 0% ROE

Model-based scoring. For information only — not financial advice.

What is TurnKey Capital Inc?

develops marijuana based intravenous therapy (IV) infusion blends for healthcare practitioners. The company was incorporated in 2018 and is headquartered in Ft. The company is listed on the PINK in USA, operating in the Technology sector, with a market capitalisation of 59.77M.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Profitability metrics are mixed — margins may be under pressure.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (47)

The scoring profile indicates limited reward potential at this time, with growth and momentum offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorTechnology
Market Cap59.77M
P/E RatioN/A
Dividend YieldN/A
52 Week High2
52 Week Low0.1
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding424M
No. of EmployeesN/A
IndustrySoftware - Application
ExchangePINK
Beta3.037
CurrencyUSD
Websitehealthspanmed.org
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.